Ionis Pharmaceuticals, Inc. Earnings

Ionis Pharmaceuticals, Inc.’s revenue fell -10.41% since last year same period to $203Mn in the Q4 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 29.53% jump in its revenue since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit fell -119.46% since last year same period to $-229Mn in the Q4 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -78.06% fall in its net profits since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit margin fell -144.94% since last year same period to -112.81% in the Q4 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -37.47% fall in its net profit margins since last 3-months.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.78 - a 41.43% jump from last quarter’s estimates.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.78.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Ionis Pharmaceuticals, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.